About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 206730, 6 pages
http://dx.doi.org/10.1155/2012/206730
Research Article

Family History of Autoimmune Disease in Patients with Aicardi-Goutières Syndrome

1Department of Neurology, Children's National Medical Center, Washington, DC 20010, USA
2Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC 20010, USA
3Unit of Child Neurology and Psychiatry, C. Mondino National Institute of Neurology Foundation, Pavia 27100, Italy
4Department of Child and Adolescent Neuropsychiatry, University of Brescia, Brescia 25123, Italy

Received 17 June 2012; Accepted 1 October 2012

Academic Editor: Timothy B. Niewold

Copyright © 2012 Johanna L. Schmidt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. J. Crow and J. H. Livingston, “Aicardi-Goutières syndrome: an important Mendelian mimic of congenital infection,” Developmental Medicine and Child Neurology, vol. 50, no. 6, pp. 410–416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Lebon, J. Badoual, G. Ponsot, F. Goutieres, F. Hemeury-Cukier, and J. Aicardi, “Intrathecal synthesis of interferon-α in infants with progressive familial encephalopathy,” Journal of the Neurological Sciences, vol. 84, no. 2-3, pp. 201–208, 1988. View at Scopus
  3. N. Blau, L. Bonafé, I. Krägeloh-Mann et al., “Cerebrospinal fluid pterins and folates in Aicardi-Goutières syndrome: a new phenotype,” Neurology, vol. 61, no. 5, pp. 642–647, 2003. View at Scopus
  4. E. Wassmer, J. Singh, S. Agrawal, S. Santra, and Y. J. Crow, “Elevated pterins in cerebral spinal fluid—biochemical marker of Aicardi-Goutières syndrome,” Developmental Medicine and Child Neurology, vol. 51, no. 10, pp. 841–842, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Aicardi and F. Goutieres, “Systemic lupus erythematosus or Aicardi-Goutières syndrome?” Neuropediatrics, vol. 31, no. 3, article 113, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. J. Crow, D. N. Black, M. Ali et al., “Cree encephalitis is allelic with aicardi-goutières syndrome: implications for the pathogenesis of disorders of interferon α metabolism,” Journal of Medical Genetics, vol. 40, no. 3, pp. 183–187, 2003. View at Scopus
  7. C. de Laet, P. Goyens, C. Christophe, A. Ferster, F. Mascart, and B. Dan, “Phenotypic overlap between infantile systemic lupus erythematosus and Aicardi-Goutières syndrome,” Neuropediatrics, vol. 36, no. 6, pp. 399–402, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. R. C. Dale, S. Ping Tang, J. Z. Heckmatt, and F. M. Tatnall, “Familial systemic lupus erythematosus and congenital infection-like syndrome,” Neuropediatrics, vol. 31, no. 3, pp. 155–158, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Lee-Kirsch, M. Gong, D. Chowdhury et al., “Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus,” Nature Genetics, vol. 39, no. 9, pp. 1065–1067, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Namjou, P. H. Kothari, J. A. Kelly et al., “Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort,” Genes and Immunity, vol. 12, no. 4, pp. 270–279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Günther, M. Meurer, A. Stein, A. Viehweg, and M. A. Lee-Kirsch, “Familial chilblain lupus—a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1,” Dermatology, vol. 219, no. 2, pp. 162–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Rice, W. G. Newman, J. Dean et al., “Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutières syndrome,” American Journal of Human Genetics, vol. 80, no. 4, pp. 811–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Ravenscroft, M. Suri, G. I. Rice, M. Szynkiewicz, and Y. J. Crow, “Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus,” American Journal of Medical Genetics A, vol. 155, no. 1, pp. 235–237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Richards, A. M. J. M. van den Maagdenberg, J. C. Jen et al., “C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy,” Nature Genetics, vol. 39, no. 9, pp. 1068–1070, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. D. C. Goldstone, V. Ennis-Adeniran, J. J. Hedden, et al., “HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase,” Nature, vol. 480, no. 7377, pp. 379–382, 2011. View at Publisher · View at Google Scholar
  16. G. I. Rice, J. Bond, A. Asipu, et al., “Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response,” Nature Genetics, vol. 41, no. 7, pp. 829–832, 2009. View at Publisher · View at Google Scholar
  17. D. B. Stetson, J. S. Ko, T. Heidmann, and R. Medzhitov, “Trex1 prevents cell-intrinsic initiation of autoimmunity,” Cell, vol. 134, no. 4, pp. 587–598, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. L. Jacobson, S. J. Gangea, N. R. Roseb, and N. M.H. Graham, “Epidemiology and estimated population burden of selected autoimmune diseases in the United States,” Clinical Immunology and Immunopathology, vol. 84, no. 3, pp. 223–243, 1997. View at Publisher · View at Google Scholar
  19. J. C. Prinz, “The role of T cells in psoriasis,” Journal of the European Academy of Dermatology and Venereology, vol. 17, no. 3, pp. 257–270, 2003. View at Publisher · View at Google Scholar
  20. J. C. Diniz, R. T. Almeida, N. E. Aikawa, A. Sallum, P. T. Sakane, and C. A. Silva, “Kawasaki disease and juvenile systemic lupus erythematosus,” Lupus, vol. 21, no. 1, pp. 89–92, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. J. Crow, “Type I interferonopathies: a novel set of inborn errors of immunity,” Annals of the New York Academy of Sciences, vol. 1238, no. 1, pp. 91–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. B. Niewold, J. Hua, T. J. A. Lehman, J. B. Harley, and M. K. Crow, “High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus,” Genes and Immunity, vol. 8, no. 6, pp. 492–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. T. B. Niewold, S. C. Wu, M. Smith, G. A. Morgan, and L. M. Pachman, “Familial aggregation of autoimmune disease in juvenile dermatomyositis,” Pediatrics, vol. 127, no. 5, pp. e1239–e1246, 2011. View at Publisher · View at Google Scholar · View at Scopus